Studies on cancer neovascularization often use immunohistochemical EC markers (CD31, CD34, CD105) to identify newly formed microvessels in diseased tissues (in this case, NSCLC) [78,79,80,81,82,83,84]. Here, PECAM1 is linked to non-small cell lung carcinoma.